{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T18:09:31Z","timestamp":1778954971996,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00216-025-05944-7","type":"journal-article","created":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T22:44:23Z","timestamp":1750027463000},"page":"4311-4329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Understanding the chemical stability of peptidomimetic therapeutics using high-resolution mass spectrometry: a study of terlipressin and its degradation products"],"prefix":"10.1007","volume":"417","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1064-9223","authenticated-orcid":false,"given":"Ashwini","family":"Chawathe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-3146","authenticated-orcid":false,"given":"Nitish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"5944_CR1","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ICH harmonised tripartite guideline stability testing of new drug substances and products Q1A(R2). 2003."},{"key":"5944_CR2","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ICH harmonised tripartite guideline quality of biotechnological products: stability testing of biotechnological\/biological products Q5C Current Step 4 version. 1995."},{"key":"5944_CR3","unstructured":"Grand View Research. Peptide therapeutics market size, industry report, 2030. n.d. Available at https:\/\/www.grandviewresearch.com\/industry-analysis\/peptide-therapeutics-market. Accessed 04\/06\/2025."},{"key":"5944_CR4","doi-asserted-by":"publisher","unstructured":"Badgujar D, Bawake S, Sharma N. A comprehensive study on the identification and characterization of major degradation products of synthetic liraglutide using liquid chromatography\u2010high resolution mass spectrometry. J Pept Sci. 2025;31. https:\/\/doi.org\/10.1002\/psc.3652.","DOI":"10.1002\/psc.3652"},{"key":"5944_CR5","unstructured":"FDA, CDER. HIGHLIGHTS OF PRESCRIBING INFORMATION for TERLIVAZ (terlipressin) for injection, for intravenous use. 2022. Available at https:\/\/www.Mallinckrodt.com. Accessed 04\/06\/2025."},{"key":"5944_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.drudis.2016.11.003","volume":"22","author":"N Qvit","year":"2017","unstructured":"Qvit N, Rubin SJS, Urban TJ, Mochly-Rosen D, Gross ER. Peptidomimetic therapeutics: scientific approaches and opportunities. Drug Discov Today. 2017;22:454\u201362. https:\/\/doi.org\/10.1016\/j.drudis.2016.11.003.","journal-title":"Drug Discov Today"},{"key":"5944_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpba.2015.01.009","volume":"109","author":"M Johnson","year":"2015","unstructured":"Johnson M, Liu M, Struble E, Hettiarachchi K. Characterization of cyclic peptides containing disulfide bonds. J Pharm Biomed Anal. 2015;109:112\u201320. https:\/\/doi.org\/10.1016\/j.jpba.2015.01.009.","journal-title":"J Pharm Biomed Anal"},{"key":"5944_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10337-024-04352-w","volume":"87","author":"C Salva","year":"2024","unstructured":"Salva C, Galla R. The novel quality by design concept in the development and validation of a stability-indicating RP-HPLC PDA method for estimating Terlipressin in an injectable dosage form. Chromatographia. 2024;87:567\u201379. https:\/\/doi.org\/10.1007\/s10337-024-04352-w.","journal-title":"Chromatographia"},{"key":"5944_CR9","unstructured":"Kumar PM, Sreeramulu and J. Stability indicating RP-HPLC method for simultaneous determination of Terlipressin in pure and pharmaceutical formulation. J Chem Pharm Res 2010;2:424\u201332."},{"key":"5944_CR10","doi-asserted-by":"publisher","unstructured":"Author C, Dhange BS. 947-953 |Research. Int J of Pharm Sci 2024;2. https:\/\/doi.org\/10.5281\/zenodo.11214748.","DOI":"10.5281\/zenodo.11214748"},{"key":"5944_CR11","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s00216-021-03154-5","volume":"413","author":"M Li","year":"2021","unstructured":"Li M, Josephs RD, Daireaux A, Choteau T, Westwood S, Martos G, et al. Structurally related peptide impurity identification and accurate quantification for synthetic oxytocin by liquid chromatography\u2013high-resolution mass spectrometry. Anal Bioanal Chem. 2021;413:1861\u201370. https:\/\/doi.org\/10.1007\/s00216-021-03154-5.","journal-title":"Anal Bioanal Chem"},{"key":"5944_CR12","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ICH harmonised tripartite guideline validation of analytical procedures: text and methodology Q2(R1). n.d."},{"key":"5944_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/biom11030462","volume":"11","author":"RR Lopes","year":"2021","unstructured":"Lopes RR, Tom\u00e9 CS, Russo R, Paterna R, Leandro J, Candeias NR, et al. Modulation of human phenylalanine hydroxylase by 3-hydroxyquinolin-2(1H)-one derivatives. Biomolecules. 2021;11:462. https:\/\/doi.org\/10.3390\/biom11030462.","journal-title":"Biomolecules"},{"key":"5944_CR14","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1039\/D3OB00179B","volume":"21","author":"MR Bhatt","year":"2023","unstructured":"Bhatt MR, Zondlo NJ. Synthesis and conformational preferences of peptides and proteins with cysteine sulfonic acid. Org Biomol Chem. 2023;21:2779\u2013800. https:\/\/doi.org\/10.1039\/D3OB00179B.","journal-title":"Org Biomol Chem"},{"key":"5944_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/jms.3831","volume":"51","author":"AL Pilo","year":"2016","unstructured":"Pilo AL, Peng Z, McLuckey SA. The dehydroalanine effect in the fragmentation of ions derived from polypeptides. J Mass Spectrom. 2016;51:857\u201366. https:\/\/doi.org\/10.1002\/jms.3831.","journal-title":"J Mass Spectrom"},{"key":"5944_CR16","doi-asserted-by":"publisher","first-page":"13032","DOI":"10.1021\/acs.analchem.9b03127","volume":"91","author":"DL Riggs","year":"2019","unstructured":"Riggs DL, Silzel JW, Lyon YA, Kang AS, Julian RR. Analysis of glutamine deamidation: products, pathways, and kinetics. Anal Chem. 2019;91:13032\u20138. https:\/\/doi.org\/10.1021\/acs.analchem.9b03127.","journal-title":"Anal Chem"},{"key":"5944_CR17","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1016\/S0040-4039(00)73228-X","volume":"35","author":"B Parmentier","year":"1994","unstructured":"Parmentier B, Moutiez M, Tartar A, Sergheraert C. Preparation of trisulfide derivatives of cystine and their formation as by-products during peptide synthesis. Tetrahedron Lett. 1994;35:3531\u20134. https:\/\/doi.org\/10.1016\/S0040-4039(00)73228-X.","journal-title":"Tetrahedron Lett"},{"key":"5944_CR18","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/jps.23906","volume":"103","author":"S Chandrasekhar","year":"2014","unstructured":"Chandrasekhar S, Epling DE, Sophocleous AM, Topp EM. Thiol-disulfide exchange in peptides derived from human growth hormone. J Pharm Sci. 2014;103:1032\u201342. https:\/\/doi.org\/10.1002\/jps.23906.","journal-title":"J Pharm Sci"},{"key":"5944_CR19","unstructured":"Moon Y-K, Wang X, Guo D. Preparation method of Terlipressin; 2011. Available at https:\/\/patents.google.com\/patent\/CN102408471A\/en. Accessed 04\/06\/2025."},{"key":"5944_CR20","unstructured":"Markham P. Formulations of Terlipressin; 2020. Available at https:\/\/patents.google.com\/patent\/WO2020237170A1\/en. Accessed 04\/06\/2025."},{"key":"5944_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0116-z","volume":"50","author":"R Ree","year":"2018","unstructured":"Ree R, Varland S, Arnesen T. Spotlight on protein N-terminal acetylation. Exp Mol Med. 2018;50:1\u201313. https:\/\/doi.org\/10.1038\/s12276-018-0116-z.","journal-title":"Exp Mol Med"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-025-05944-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-025-05944-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-025-05944-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T08:35:31Z","timestamp":1753173331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-025-05944-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":21,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["5944"],"URL":"https:\/\/doi.org\/10.1007\/s00216-025-05944-7","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}